The National Institutes of Health (NIH) Office of Biotechnology Activities (OBA) will conduct a site visit at Emory’s main campus on March 18th, 2014. During the site visit, the team will review and evaluate the institution’s compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The site visit will primarily focus on evaluation of the University’s Institutional Biosafety Committee and the oversight program for research subject to the NIH Guidelines.
-
Recent Articles for Emory’s Research Administrator
- Message from VPRA, Dr. Robert Nobles (March 2024)
- RGC Policies Summary
- Biological Safety Protocol Electronic Submission
- Sponsored Research: The Importance of Obtaining Approvals Before Starting Work
- RCRA Minimizing Administrative Burden While Maintaining Compliance
- OTT Plans to Introduce New and Improved Process for Outgoing Low-Risk DUAs
- Occupational Health Services (OHS)
- Research Compliance News and Updates (January 2024)
- HHS Office of Research Integrity (ORI) Notice of Proposed Rule Making (NPRM)
- NIH Workplace Conduct Requirements
New from NIH
- Increases for National Research Service Award Stipends and Childcare Subsidies April 23, 2024We are committed to sustaining the vitality of the future biomedical research workforce, including providing appropriate support and addressing the many challenges faced by postdoctoral scholars in biomedicine. As part of this commitment, we are pleased to announce stipend and childcare subsidy increases for the over 17,000 early career scholars supported on NIH Kirschstein National […]Mike Lauer
- Increases for National Research Service Award Stipends and Childcare Subsidies April 23, 2024
News from the Office of Technology Transfer
Emails from EHSO